These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33117165)

  • 1. Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract "Transferon Oral": The Starting Point to Understand Its Mechanism of Action.
    Vallejo-Castillo L; Favari L; Vázquez-Leyva S; Mellado-Sánchez G; Macías-Palacios Z; López-Juárez LE; Valencia-Flores L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Pérez-Tapia SM
    Front Pharmacol; 2020; 11():569039. PubMed ID: 33117165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity.
    Salinas-Jazmín N; Estrada-Parra S; Becerril-García MA; Limón-Flores AY; Vázquez-Leyva S; Medina-Rivero E; Pavón L; Velasco-Velázquez MA; Pérez-Tapia SM
    J Immunol Res; 2015; 2015():146305. PubMed ID: 25984538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dialyzable leukocyte extract Transferon
    Hernández-Esquivel MA; Pérez-Torres A; Romero-Romero L; Reyes-Matute A; Loaiza B; Mellado-Sánchez G; Pavón L; Medina-Rivero E; Pestell RG; Pérez-Tapia SM; Velasco-Velázquez MA
    Biomed Pharmacother; 2018 May; 101():938-944. PubMed ID: 29635903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release.
    Carballo-Uicab G; Linares-Trejo JE; Mellado-Sánchez G; López-Morales CA; Velasco-Velázquez M; Pavón L; Estrada-Parra S; Pérez-Tapia SM; Medina-Rivero E
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31547184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants.
    Avila S; Muñoz-García L; Vázquez-Leyva S; Salinas-Jazmín N; Medina-Rivero E; Pavón L; Mellado-Sánchez G; Chacón-Salinas R; Estrada-Parra S; Vallejo-Castillo L; Pérez-Tapia SM
    J Immunotoxicol; 2017 Dec; 14(1):169-177. PubMed ID: 28707490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®).
    Mellado-Sánchez G; Lázaro-Rodríguez JJ; Avila S; Vallejo-Castillo L; Vázquez-Leyva S; Carballo-Uicab G; Velasco-Velázquez M; Medina-Rivero E; Pavón L; Chacón-Salinas R; Pérez-Tapia SM
    J Immunol Res; 2019; 2019():2754920. PubMed ID: 31223627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®).
    Jiménez-Uribe AP; Valencia-Martínez H; Carballo-Uicab G; Vallejo-Castillo L; Medina-Rivero E; Chacón-Salinas R; Pavón L; Velasco-Velázquez MA; Mellado-Sánchez G; Estrada-Parra S; Pérez-Tapia SM
    J Immunol Res; 2019; 2019():2198508. PubMed ID: 31093509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical Characteristics of Transferon™ Batches.
    Medina-Rivero E; Vallejo-Castillo L; Vázquez-Leyva S; Pérez-Sánchez G; Favari L; Velasco-Velázquez M; Estrada-Parra S; Pavón L; Pérez-Tapia SM
    Biomed Res Int; 2016; 2016():7935181. PubMed ID: 27525277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Batch-to-batch reproducibility of Transferon™.
    Medina-Rivero E; Merchand-Reyes G; Pavón L; Vázquez-Leyva S; Pérez-Sánchez G; Salinas-Jazmín N; Estrada-Parra S; Velasco-Velázquez M; Pérez-Tapia SM
    J Pharm Biomed Anal; 2014 Jan; 88():289-94. PubMed ID: 24099727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consistency of a dialyzable leucocyte extract manufactured at GMP facilities by nuclear magnetic resonance spectroscopy.
    Herbert-Pucheta JE; López-Morales CA; Medina-Rivero E; Estrada-Parra S; Pérez-Tapia SM; Zepeda-Vallejo LG
    J Pharm Biomed Anal; 2021 Mar; 196():113940. PubMed ID: 33549874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular ubiquitin increases in packed red blood cell units during storage.
    Patel MB; Proctor KG; Majetschak M
    J Surg Res; 2006 Oct; 135(2):226-32. PubMed ID: 16926027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of chemokines CTAPIII and NAP/2 by digestion of recombinant ubiquitin-CTAPIII with yeast ubiquitin C-terminal hydrolase and human immunodeficiency virus protease.
    Mildner AM; Paddock DJ; LeCureux LW; Leone JW; Anderson DC; Tomasselli AG; Heinrikson RL
    Protein Expr Purif; 1999 Jul; 16(2):347-54. PubMed ID: 10419831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals.
    Phu L; Izrael-Tomasevic A; Matsumoto ML; Bustos D; Dynek JN; Fedorova AV; Bakalarski CE; Arnott D; Deshayes K; Dixit VM; Kelley RF; Vucic D; Kirkpatrick DS
    Mol Cell Proteomics; 2011 May; 10(5):M110.003756. PubMed ID: 21048196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis.
    Vázquez-Leyva S; Vallejo-Castillo L; López-Morales CA; Herbert-Pucheta JE; Zepeda-Vallejo LG; Velasco-Velázquez M; Pavón L; Pérez-Tapia SM; Medina-Rivero E
    Anal Chem; 2019 Nov; 91(22):14392-14400. PubMed ID: 31664820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb).
    Mendoza-Salazar I; Fragozo A; González-Martínez AP; Trejo-Martínez I; Arreola R; Pavón L; Almagro JC; Vallejo-Castillo L; Aguilar-Alonso FA; Pérez-Tapia SM
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous ubiquitin reduces inflammatory response and preserves myocardial function 3 days post-ischemia-reperfusion injury.
    Scofield SLC; Dalal S; Lim KA; Thrasher PR; Daniels CR; Peterson JM; Singh M; Singh K
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H617-H628. PubMed ID: 30681370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular ubiquitin inhibits beta-AR-stimulated apoptosis in cardiac myocytes: role of GSK-3beta and mitochondrial pathways.
    Singh M; Roginskaya M; Dalal S; Menon B; Kaverina E; Boluyt MO; Singh K
    Cardiovasc Res; 2010 Apr; 86(1):20-8. PubMed ID: 20015977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 25-kilodalton ubiquitin carrier protein (E2) catalyzes multi-ubiquitin chain synthesis via lysine 48 of ubiquitin.
    Chen Z; Pickart CM
    J Biol Chem; 1990 Dec; 265(35):21835-42. PubMed ID: 2174887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization of mycobactericidal ubiquitin-derived peptides in model and bacterial membranes.
    Foss MH; Powers KM; Purdy GE
    Biochemistry; 2012 Dec; 51(49):9922-9. PubMed ID: 23173767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.